UPV-EHU ADDI
  • Back
    • English
    • Español
    • Euskera
  • Login
  • English 
    • English
    • Español
    • Euskera
  • FAQ
Search 
  •   Home
  • INVESTIGACIÓN
  • Grupos de Investigación, Institutos y Centros Colaboradores
  • ACHUCARRO
  • Search
  •   Home
  • INVESTIGACIÓN
  • Grupos de Investigación, Institutos y Centros Colaboradores
  • ACHUCARRO
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-3 of 3

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis 

González Ortega, Itxaso; Alberich, Susana; Echeburúa Odriozola, Enrique; Aizpuru Barandiaran, Felipe; Millán, Eduardo; Vieta, Eduard; Matute Almau, Carlos José; González Pinto Arrillaga, Ana María (Public Library Science, 2015-04-15)
Background Although depressive symptoms in first episode psychosis have been associated with cannabis abuse, their influence on the long-term functional course of FEP patients who abuse cannabis is unknown. The aims of ...
Thumbnail

Pio del Rio Hortega and the discovery of the oligodendrocytes 

Pérez Cerdá, Fernando; Sánchez Gómez, María Victoria; Matute Almau, Carlos José (Frontiers Research Foundation, 2015-07-07)
Rio del Rio Hortega (1882-1945) discovered microglia and oligodendrocytes (OLGs), and after Ramon y Cajal, was the most prominent figure of the Spanish school of neurology. He began his scientific career with Nicolas ...
Thumbnail

FTY720 attenuates excitotoxicity and neuroinflammation 

Cipriani, Raffaela; Chara Ventura, Juan Carlos; Rodríguez Antigüedad, Alfredo; Matute Almau, Carlos José (BioMed Central, 2015-05-08)
Background: FTY720 (fingolimod, Gilenya(TM)), a structural analog of sphingosine-1-phosphate (S1P), is the first oral drug approved for treatment the relapsing-remitting form of multiple sclerosis (MS), and its efficacy ...

DSpace software copyright © 2002-2015  DuraSpace
OpenAIRE
OpenAIRE
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesDepartamentos (cas.)Departamentos (eus.)SubjectsThis CommunityBy Issue DateAuthorsTitlesDepartamentos (cas.)Departamentos (eus.)Subjects

My Account

Login

Discover

Author
Matute Almau, Carlos José (3)
Aizpuru Barandiaran, Felipe (1)Alberich, Susana (1)Chara Ventura, Juan Carlos (1)... View MoreDepartamento (cas.)Neurociencias (3)Departamento (eus.)Neurozientziak (3)SubjectCELLULAR AND MOLECULAR NEUROSCIENCE (2)AGRICULTURAL AND BIOLOGICAL SCIENCES (1)ANATOMY AND MORPHOLOGY (1)BIOCHEMISTRY AND MOLECULAR BIOLOGY (1)... View MoreDate Issued
2015 (3)
Language(ISO)eng (3)

DSpace software copyright © 2002-2015  DuraSpace
OpenAIRE
OpenAIRE